Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy

Genitourinary CancerRadio-Oncology

Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients

BJU Int.

Crouzet S, Blana A, Murat FJ, Pasticier G, Brown SCW, Conti GN, Ganzer R, Chapet O, Gelet A, Chaussy CG, Robertson CN, Thuroff S, Ward JF

doi: 10.1111/bju.13766.

Genitourinary CancerRadio-Oncology

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

Urol Case Rep.

Bandini M, Gandaglia G, Fossati N, Montorsi F, Briganti A

doi: 10.1016/j.eucr.2017.02.011.

Genitourinary Cancer

Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy

J Urol.

Robertson NL, Sala E, Benz M, Landa J, Scardino P, Scher HI, Hricak H, Vargas HA

doi: 10.1016/j.juro.2017.02.071.

Genitourinary Cancer

Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

N Engl J Med.

Wilt TJ, Jones KM, Barry MJ, Andriole GL, Culkin D, Wheeler T, Aronson WJ, Brawer MK

doi: 10.1056/NEJMoa1615869.

Genitourinary Cancer

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT

Urol Case Rep.

Gergelis KR, Remme DS, Choo CR

doi: 10.1016/j.eucr.2019.100985.

Genitourinary Cancer

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

Prostate Cancer Prostatic Dis.

Nguyen PL, Martin NE, Choeurng V, Palmer-Aronsten B, Kolisnik T, Beard CJ, Orio PF, Nezolosky MD, Chen YW, Shin H, Davicioni E, Feng FY

doi: 10.1038/pcan.2016.58.

Genitourinary Cancer

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

BJU Int.

Loeb S, Shin SS, Broyles DL, Wei JT, Sanda M, Klee G, Partin AW, Sokoll L, Chan DW, Bangma CH, van Schaik RHN, Slawin KM, Marks LS, Catalona WJ

doi: 10.1111/bju.13676.

Gastrointestinal Cancer

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer

J Surg Oncol.

Sho S, Court CM, Winograd P, Russell MM, Tomlinson JS

doi: 10.1002/jso.24781.

Genitourinary Cancer

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

Prostate.

Markowski MC, Shenderov E, Eisenberger MA, Kachhap S, Pardoll DM, Denmeade SR, Antonarakis ES

doi: 10.1002/pros.23955.

Related content

Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy

Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer